Metaanalysis of Multivessel vs Culprit Artery Only Percutaneous Coronary Intervention in ST Elevation Myocardial

Daniel C Garcia1, Alexandre M Benjo1, Christopher J White1,2

  • 1Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA.

Ochsner Journal
|July 2, 2019
PubMed

Insights

Multivessel percutaneous coronary intervention (PCI) significantly reduces mortality and reinfarction in ST-elevation myocardial infarction (STEMI) patients without cardiogenic shock compared to culprit artery only PCI. This strategy offers improved outcomes for STEMI treatment.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Trials and Meta-Analysis

Background:

  • Primary percutaneous coronary intervention (PCI) is standard for ST-elevation myocardial infarction (STEMI).
  • Current guidelines favor culprit artery only PCI.
  • Emerging data suggest potential benefits of multivessel PCI in select STEMI patients.

Purpose of the Study:

  • To evaluate the efficacy of multivessel PCI versus culprit artery only PCI in STEMI patients without cardiogenic shock.
  • To assess the impact on mortality, reinfarction, and repeat revascularization.

Main Methods:

  • Systematic search of PubMed, EMBASE, and Cochrane Central Register of Controlled Trials.
  • Inclusion of four randomized clinical trials (1,044 patients) comparing multivessel PCI to culprit artery only PCI.
  • Outcomes analyzed: all-cause mortality, cardiovascular mortality, reinfarction, and repeat revascularization.

Main Results:

  • Multivessel PCI was performed in 566 patients; culprit artery only PCI in 478.
  • Multivessel PCI significantly reduced all-cause mortality, cardiac death, reinfarction, and repeat revascularization (P < 0.05).
  • This meta-analysis represents the largest randomized controlled trial evaluation of this comparison in STEMI without shock.

Conclusions:

  • Multivessel PCI strategy is superior to culprit artery only PCI in STEMI patients without cardiogenic shock.
  • The multivessel approach leads to significant reductions in mortality and reinfarction rates.
  • Angiography alone was used for lesion severity grading in this analysis.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
606
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
39.6K